Invictus RG’s Globus Medical GMED Stock Holding History

Invictus RG’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,074	Closed	-$303K	–	253
2018 Q1	$303K	Buy	+6,074	New	+$285K	0.2%	141
2017 Q4	–	Sell	-1,329	Closed	-$39K	–	340
2017 Q3	$39K	Sell	1,329 -1,030	-44%	-$31.4K	0.04%	387
2017 Q2	$78K	Buy	+2,359	New	+$74.1K	0.06%	416
2016 Q3	–	Sell	-5,381	Closed	-$128K	–	703
2016 Q2	$128K	Buy	+5,381	New	+$129K	0.14%	260

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invictus RG's GMED Position: Q2 2018 in Review

Invictus RG sold out of Globus Medical (GMED) in Q2 2018, closing a stake of 6,074 shares — an estimated $303K sold.

Invictus RG first reported a position in GMED in Q2 2016 and held it in 4 quarters. The position peaked at $303K in Q1 2018. 290 funds tracked by Wall St. Rank hold GMED as of Q2 2018.

Invictus RG reported no remaining Globus Medical position as of Q2 2018 after selling out during the quarter.
Invictus RG sold 6,074 Globus Medical shares in Q2 2018, an estimated $303K.
Invictus RG first reported a position in Globus Medical in Q2 2016 and held it in 4 quarters.
Invictus RG's Globus Medical position peaked at $303K in Q1 2018.
290 funds tracked by Wall St. Rank held Globus Medical as of Q2 2018.

Based on Invictus RG's 13F filing for Q2 2018, filed 13 Aug 2018.